SUPRANE

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey.

Active ingredients

The drug SUPRANE contains one active pharmaceutical ingredient (API):

1
UNII CRS35BZ94Q - DESFLURANE
 

Desflurane is one of a family of halogenated methyl ethyl ethers, which are administered by inhalation, producing a dose-related temporary loss of consciousness and of pain sensations, suppression of voluntary motor activity, reduction of autonomic reflexes, and depression of respiration and the cardiovascular system.

 
Read more about Desflurane

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N01AB07 Desflurane N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AB Halogenated hydrocarbons
Discover more medicines within N01AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02227428
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 21.280-1-05-04
EE Ravimiamet 1023758, 1825332
ES Centro de información online de medicamentos de la AEMPS 60554
FI Lääkealan turvallisuus- ja kehittämiskeskus 043632
FR Base de données publique des médicaments 65421851
HK Department of Health Drug Office 51461
HR Agencija za lijekove i medicinske proizvode HR-H-368795278
JP 医薬品医療機器総合機構 1119703G1024
MT Medicines Authority MA1277/04501
MX Comisión Federal para la Protección contra Riesgos Sanitarios 540M96
NL Z-Index G-Standaard 15959708
NL Z-Index G-Standaard, PRK 42471
NZ Medicines and Medical Devices Safety Authority 7164
PL Rejestru Produktów Leczniczych 100085708
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W69338001, W69338002
SG Health Sciences Authority 08818P
TN Direction de la Pharmacie et du Médicament 16973021H
TR İlaç ve Tıbbi Cihaz Kurumu 8681413881398, 8681413881404
US FDA, National Drug Code 10019-641, 10019-644, 10019-646, 52584-641
ZA Health Products Regulatory Authority 31/2.1/0417

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.